Hansa Biopharma presented new data on imlifidase at the European Society for Organ Transplantation (ESOT) Congress ...Middle East

News by : (PR Newswire) -
LUND, Sweden, Sept. 1, 2021 /PRNewswire/ -- Hansa Biopharma, "Hansa" (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare immunological conditions, today announced two abstracts presented at the European Society for Organ Transplantation (ESOT) Congress, August 29-September...

Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma presented new data on imlifidase at the European Society for Organ Transplantation (ESOT) Congress )

Also on site :

Most Viewed News
جديد الاخبار